Table 5.
Time Points (Days) | Scores | AUC | Se | Sp | PPV | NPV | PV |
---|---|---|---|---|---|---|---|
% | % | % | % | % | |||
CTP | 0.709 | 56 | 83 | 77 | 65 | 69 | |
MELD | 0.590 | 36 | 77 | 39 | 55 | 57 | |
30 | BCLC | 0.670 | 68 | 58 | 34 | 54 | 63 |
NLR | 0.618 | 53 | 68 | 62 | 59 | 87 | |
PLR | 0.567 | 58 | 51 | 54 | 55 | 55 | |
CTP | 0.667 | 51 | 76 | 68 | 61 | 63 | |
MELD | 0.502 | 33 | 25 | 70 | 27 | 29 | |
60 | BCLC | 0.637 | 66 | 57 | 33 | 62 | 61 |
NLR | 0.680 | 53 | 75 | 68 | 61 | 64 | |
PLR | 0.591 | 57 | 53 | 55 | 55 | 55 | |
CTP | 0.563 | 47 | 65 | 57 | 57 | 63 | |
MELD | 0.352 | 31 | 55 | 59 | 54 | 43 | |
90 | BCLC | 0.330 | 57 | 0.0 | 28 | 0 | 28 |
NLR | 0.613 | 50 | 71 | 63 | 59 | 50 | |
PLR | 0.688 | 60 | 70 | 67 | 64 | 65 |
Note: All values are rounded to the next integer.
Abbreviations: AUC, area under the receiver operating characteristic curve; Se, sensitivity; Sp, specificity; PPV, positive predictive value; NPV, negative predictive value; PV, prognostic value: TP+TN/(TP+TN+FP+FN); CTP, Child–Turcotte–Pugh; MELD, model for end-stage liver disease; BCLC, Barcelona clinic liver cancer; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.